ADVERSE REACTIONS
(listed alphabetically, under each subsection)
Allergic reactions Anaphylactoid reaction, anaphylaxis, angioedema.
Cardiovascular Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction (see WARNINGS), pulmonary edema, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis.
Dermatologic Acne, allergic dermatitis, dry scaly skin, ecchymoses and petechiae, edema, erythema, impaired wound healing, increased sweating, rash, striae, suppressed reactions to skin tests, thin fragile skin, thinning scalp hair, urticaria.
Endocrine Decreased carbohydrate and glucose tolerance, development of cushingoid state, glycosuria, hirsutism, hypertrichosis, increased requirements for insulin or oral hypoglycemic agents in diabetes, manifestations of latent diabetes mellitus, menstrual irregularities, secondary adrenocortical and pituitary unresponsiveness (particularly in times of stress, as in trauma, surgery, or illness), suppression of growth in pediatric patients.
Fluid and Electrolyte Disturbances Congestive heart failure in susceptible patients, fluid retention, hypokalemic alkalosis, potassium loss, sodium retention.
Gastrointestinal Abdominal distention, elevation in serum liver enzyme levels (usually reversible upon discontinuation), hepatomegaly, increased appetite, nausea, pancreatitis, peptic ulcer with possible perforation and hemorrhage, perforation of the small and large intestine (particularly in patients with inflammatory bowel disease), ulcerative esophagitis.
Metabolic Negative nitrogen balance due to protein catabolism.
Musculoskeletal Aseptic necrosis of femoral and humeral heads, loss of muscle mass, muscle weakness, osteoporosis, pathologic fracture of long bones, steroid myopathy, tendon rupture, vertebral compression fractures.
Neurologic/Psychiatric Convulsions, depression, emotional instability, euphoria, headache, increased intracranial pressure with papilledema (pseudotumor cerebri) usually following discontinuation of treatment, insomnia, mood swings, neuritis, neuropathy, paresthesia, personality changes, psychic disorders, vertigo.
Ophthalmic Exophthalmos, glaucoma, increased intraocular pressure, posterior subcapsular cataracts.
Other Abnormal fat deposits, decreased resistance to infection, hiccups, increased or decreased motility and number of spermatozoa, malaise, moon face, weight gain.
|
REPORTS OF SUSPECTED CELESTONE SIDE EFFECTS / ADVERSE REACTIONS
Below is a sample of reports where side effects / adverse reactions may be related to Celestone. The information is not vetted and should not be considered as verified clinical evidence.
Possible Celestone side effects / adverse reactions in 10 year old male
Reported by a health professional (non-physician/pharmacist) from Canada on 2011-11-29
Patient: 10 year old male
Reactions: Maternal Exposure During Pregnancy
Suspect drug(s):
Celestone
Possible Celestone side effects / adverse reactions in 51 year old male
Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-02
Patient: 51 year old male
Reactions: Hiccups
Adverse event resulted in: disablity
Suspect drug(s):
Celestone
Dosage: 6.5 mg; once; ia
Indication: Arthritis
Start date: 2011-10-11
Lasix
Dosage: 40 mg; qd; po
Administration route: Oral
Start date: 2011-10-11
Other drugs received by patient: Aspirin; Glucosamine
Possible Celestone side effects / adverse reactions in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-07
Patient: 43 year old male weighing 152.4 kg (335.3 pounds)
Reactions: Pulmonary Hypertension, Electrocardiogram T Wave Amplitude Decreased, Impaired Work Ability, Wound, Constipation, Chronic Obstructive Pulmonary Disease, Pericardial Effusion, Myalgia, Fatigue, Oedema, White Blood Cell Count Increased, Cardiac Failure Congestive, Product Quality Issue, Blood Pressure Increased, Back Pain, Blood Urine Present, Cellulitis, Neutrophil Count Increased, Drug Hypersensitivity, Decreased Activity, Skin Hypopigmentation, Rash, Diverticulum Intestinal, Myopathy, Heart Rate Increased, Infection
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Celestone
Dosage: intramuscular
Indication: Dermatitis Contact
Start date: 2011-03-23
End date: 2011-03-23
Dexamethasone Sodium Phosphate
Dosage: 8 mg x 2 doses
Indication: Dermatitis Contact
Start date: 2011-03-23
End date: 2011-04-01
Dexamethasone Sodium Phosphate
Dosage: 8 mg x 2 doses
Indication: Dermatitis Contact
Start date: 2011-03-23
End date: 2011-04-01
Other drugs received by patient: Furosemide; Adipex; Viagra; Potassium Chloride; Losartan Potassium
|